Quadruple mutation GCAC1809-1812TTCT leads to a better prognosis by decreasing HBV-mediated fibrogenic activity - Görgülü, E.; Basic, M.; Glitscher, M.; Thiyagarajah, K.; Schollmeier, A.; Kubesch, A.; Dietz, J.; Zeuzem, S.; Sarrazin, C.; Peiffer, K.-H.; Hildt, E. (Zeitschrift für Gastroenterologie, 2023)